Skip to main content
. 2022 Feb 21;29(5):2805–2811. doi: 10.1245/s10434-022-11416-4

Table 7.

Survival (percentage and 95% confidence intervals) between 6 and 10 years after surgery for esophageal cancer, stratified by Charlson comorbidity index

Year Number Observed survival Relative survival
Charlson comorbidity index 0
6 355 95.8 (93.7–97.9) 98.0 (95.9–100.1)
7 312 91.2 (88.2–94.2) 95.5 (93.3–98.6)
8 258 87.6 (84.0–91.3) 93.9 (90.1–97.8)
9 225 83.7 (79.6–87.9) 91.5 (86.9–96.1)
10 191 79.8 (75.1–84.5) 89.3 (84.0–94.6)
Charlson comorbidity index 1
6 250 94.4 (91.6–97.3) 96.7 (93.8–99.6)
7 217 85.7 (81.2–90.2) 89.9 (85.2–94.6)
8 178 74.6 (68.7–80.4) 86.2 (80.5–91.8)
9 149 74.6 (68.7–80.4) 83.0 (76.5–87.5)
10 121 68.4 (61.9–74.9) 78.4 (71.0–85.9)
Charlson comorbidity index 2
6 157 87.9 (82.8–93.0) 90.7 (85.5–96.0)
7 124 82.9 (76.9–88.9) 88.1 (81.7–94.4)
8 104 76.6 (69.6–83.5) 84.4 (76.7–92.1)
9 89 72.3 (64.7–79.8) 82.9 (74.3–91.5)
10 79 65.9 (57.6–74.1) 78.7 (68.9–88.6)